JPS6419018A - Cholesterol depressing agent - Google Patents

Cholesterol depressing agent

Info

Publication number
JPS6419018A
JPS6419018A JP17382687A JP17382687A JPS6419018A JP S6419018 A JPS6419018 A JP S6419018A JP 17382687 A JP17382687 A JP 17382687A JP 17382687 A JP17382687 A JP 17382687A JP S6419018 A JPS6419018 A JP S6419018A
Authority
JP
Japan
Prior art keywords
acid
cis
active compound
compounds selected
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17382687A
Other languages
Japanese (ja)
Inventor
Shigeo Iwamoto
Mitsunobu Masuzawa
Kazuo Tsuruoka
Yoshihiro Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
Nippon Oil and Fats Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Oil and Fats Co Ltd filed Critical Nippon Oil and Fats Co Ltd
Priority to JP17382687A priority Critical patent/JPS6419018A/en
Publication of JPS6419018A publication Critical patent/JPS6419018A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain the titled agent free from side effect such as hepatic disorder and having excellent effect, by using one or more compounds selected from 9,12,15-cis-octadecatrienoic acid and 5,8,11,14-cis-eicosatetraenoic acid as an active component. CONSTITUTION:The objective agent contains one or more compounds selected from 9,12,15-cis-octadecatrienoic acid, its acid derivative, 5,8,11,14-cis- eicosatetraenoic acid and its acid derivative as active components. The above active compound is mixed with a conventional preparation raw material such as gelatin, casein or lactose and formed in the form suitable for oral administration or subcutaneous injection, etc. (e.g. capsule or tablet). The amount of the active compound in the drug preparation is >=0.1g per 1kg of the body weight. The active compound is present at a small amount as a fatty acid composition in natural oils and fats such as linseed oil or soybean oil.
JP17382687A 1987-07-14 1987-07-14 Cholesterol depressing agent Pending JPS6419018A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17382687A JPS6419018A (en) 1987-07-14 1987-07-14 Cholesterol depressing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17382687A JPS6419018A (en) 1987-07-14 1987-07-14 Cholesterol depressing agent

Publications (1)

Publication Number Publication Date
JPS6419018A true JPS6419018A (en) 1989-01-23

Family

ID=15967872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17382687A Pending JPS6419018A (en) 1987-07-14 1987-07-14 Cholesterol depressing agent

Country Status (1)

Country Link
JP (1) JPS6419018A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents

Similar Documents

Publication Publication Date Title
JPS55153713A (en) Pharmaceutical preparation of ribosome containing active substance
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
GB2084172A (en) Lipid compositions useful in dietetics
ES2036199T3 (en) PROCEDURE FOR OBTAINING AN ADMINISTRABLE PHARMACEUTICAL PREPARATION THROUGH A BODY MEMBRANE.
JPS6413021A (en) Lithium salt-containing pharmacological composition
US4827062A (en) Composition containing ubidecarenone with absorption promoted
ES482357A1 (en) Prostanoid compounds and compositions
JPS57128634A (en) Elastase-containing compound increasing absorption
EP0734723A1 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
JPS5622724A (en) Pharmaceutical preparation of n4-acylcytosine arabinoside
EP0366480A3 (en) Method and compositions for treating alzheimer's disease, related dementias & epilepsy
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
ZA872868B (en) The liquidization of pharmaceutical preparations for filling soft gelatine capsules therewith
JPS6419018A (en) Cholesterol depressing agent
JPS52806A (en) Preparation of ester
EP0162924A4 (en) 5-fluorouracil derivatives and medicinal preparation containing same.
JPS5446821A (en) Preparation of drug for soft capsule
JPS56115715A (en) Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative
JPS52130905A (en) Medicinal composition
JPS55360A (en) Lubricant composition for tableted drugs and confection
JPS5564755A (en) Shortening for "baumkuchen" (germany cake)
JPS57209216A (en) Compound fat-soluble vitamin injection capable of being medicated by venoclysis and its preparation
JPS55105623A (en) Preparation of filler for hard capsules
JPS57149219A (en) Hard capsule preparation containing tocopherol nicotinate in high concentration
JPS55129218A (en) Pharmaceutical preparation for remedy and prevention of diabetes and administrable orally or through small intestine